首页 | 本学科首页   官方微博 | 高级检索  
     检索      

5-氟脲嘧啶120小时持续滴注加顺铂治疗晚期食管癌(附19例临床分析)
引用本文:张珍华,李蓉,张哲舫.5-氟脲嘧啶120小时持续滴注加顺铂治疗晚期食管癌(附19例临床分析)[J].西安交通大学学报(医学版),1989(3).
作者姓名:张珍华  李蓉  张哲舫
作者单位:西安医科大学第一附属医院肿瘤科 (张珍华,李蓉),西安医科大学第一附属医院肿瘤科(张哲舫)
摘    要:本文报道我科于1985年5月~1987年7月应用5-氟脲嘧啶120h 持续静脉滴注加顺铂治疗21例晚期食管癌的近期结果。在可评价疗效的19例中完全缓解1例(5.5%),部分缓解8例(42.1%),稳定4例(22.2%)进展6例(31.5%),有效率47.6%。本文对影响疗效的诸因素和毒性反应作了分析,认为此方案可作为晚期食管癌的姑息疗法或为综合治疗中的一部分。

关 键 词:食管癌  5-氟脲嘧啶  顺铂  化疗

120 HOUR CONTINUOUS INFUSION 5-FU AND CISPLATIN IN THE TREATMENT OF ADVANCED ESOPHAGEAL CARCINOMA(CLINICAL ANALYSIS OF 19 CASES)
Zheng Zhenhua,et al.120 HOUR CONTINUOUS INFUSION 5-FU AND CISPLATIN IN THE TREATMENT OF ADVANCED ESOPHAGEAL CARCINOMA(CLINICAL ANALYSIS OF 19 CASES)[J].Journal of Xi‘an Jiaotong University:Medical Sciences,1989(3).
Authors:Zheng Zhenhua  
Abstract:From May 1985 to July 1987,21 non-prior chemotherapy patients with advanced esophageal cancinoma were treated with 120-hour continuous infu-sion 5-Fu and cisplatin.19 patents completed at leastone to three cycle treatment.Of these,1 achieved com-plete response(5.5%),8 in partial response(42.1%), 4 was no change(22.2%)while 6 patients hadprogressive disease(31.5%).The overall responserate was 47.6%(9/19).The toxic effect was tolerablein most patients.The factors which influences responserate were discussed.The authors suggest that thisregimen should be used for palliation or part of com-bined modality therapy for the patient of advancedesophageal carcinoma.
Keywords:esophageal carcinoma  fluorouracil  cisplatin  chemotherapy
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号